Get Live Data

Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share News
  5. UK BROKER RATINGS SUMMARY: Peel Hunt Initiates Whitbread With Buy

Pin to quick picksGlaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,780.50
Bid: 1,778.50
Ask: 1,779.00
Change: 7.00 (0.39%)
Spread: 0.50 (0.028%)
Open: 1,780.00
High: 1,786.50
Low: 1,771.50
Prev. Close: 1,773.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Peel Hunt Initiates Whitbread With Buy

Mon, 04th Nov 2019 09:10

(Alliance News) - The following London-listed shares received analyst recommendations on Monday morning and Friday afternoon:

----------

FTSE 100

----------

PEEL HUNT INITIATES WHITBREAD WITH 'BUY' - TARGET 4800 PENCE

----------

UBS CUTS SAGE GROUP PRICE TARGET TO 620 (625) PENCE - 'SELL'

----------

UBS RAISES STANDARD CHARTERED PRICE TARGET TO 690 (650) PENCE - 'NEUTRAL'

----------

UBS CUTS LLOYDS PRICE TARGET TO 62 (65) PENCE - 'BUY'

----------

JPMORGAN CUTS LLOYDS PRICE TARGET TO 68 (72) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS SMITH & NEPHEW PRICE TARGET TO 1711 (1814) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS EVRAZ PRICE TARGET TO 375 (400) PENCE - 'UNDERWEIGHT'

----------

LIBERUM RAISES GLAXOSMITHKLINE PRICE TARGET TO 1890 (1510) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS VODAFONE PRICE TARGET TO 240 (250) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS RSA INSURANCE PRICE TARGET TO 560 (565) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES INTERNATIONAL CONSOLIDATED AIRLINES PRICE TARGET TO 670 (630) PENCE - 'BUY'

----------

GOLDMAN CUTS EXPERIAN PRICE TARGET TO 2500 (2600) PENCE - 'NEUTRAL'

----------

JEFFERIES CUTS IMPERIAL BRANDS PRICE TARGET TO 2400 (3800) PENCE - 'BUY'

----------

JEFFERIES CUTS BRITISH AMERICAN TOBACCO PRICE TARGET TO 4800 (4900) PENCE - 'BUY'

----------

CREDIT SUISSE CUTS RECKITT-BENCKISER-PRICE TARGET TO 5550 (5800) PENCE - UNDERPERFORM

----------

CREDIT SUISSE CUTS SMITH & NEPHEW PRICE TARGET TO 1725 (1770) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

LIBERUM RAISES PETS AT HOME TO 'BUY' ('HOLD')

----------

UBS CUTS ELEMENTIS PRICE TARGET TO 175 (185) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES CAPITA GROUP PRICE TARGET TO 140 (120) PENCE - 'HOLD'

----------

BARCLAYS RAISES WORKSPACE GROUP PRICE TARGET TO 1000 (980) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES DERWENT LONDON PRICE TARGET TO 3100 (3000) PENCE - 'UNDERWEIGHT'

----------

BARCLAYS CUTS BBA AVIATION PRICE TARGET TO 347 (350) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES FUTURE PRICE TARGET TO 1755 (1530) PENCE - 'BUY'

----------

BERENBERG CUTS MAN GROUP PRICE TARGET TO 192 (206) PENCE - 'BUY'

----------

BERENBERG CUTS BOVIS HOMES PRICE TARGET TO 1220 (1230) PENCE - 'BUY'

----------

JPMORGAN RAISES TRAVIS PERKINS PRICE TARGET TO 1400 (1356) PENCE - 'NEUTRAL'

----------

JEFFERIES CUTS WEIR GROUP PRICE TARGET TO 1395 (1440) PENCE - 'HOLD'

----------

OTHER MAIN MARKET AND AIM

----------

LIBERUM CUTS LOOKERS TO 'HOLD' ('BUY') - TARGET 30 (68) PENCE

----------

BERENBERG RAISES CHEMRING GROUP PRICE TARGET TO 200 (190) PENCE - 'HOLD

----------

BERENBERG RAISES TEAM17 PRICE TARGET TO 375 (330) PENCE - 'BUY'

----------

JPMORGAN CUTS FEVERTREE DRINKS PRICE TARGET TO 2400 (2740) PENCE - 'OVERWEIGHT'

----------

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
18 Sep 2023 09:40

LONDON BROKER RATINGS: Jefferies likes Energean; JPMorgan raises IDS

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
18 Sep 2023 07:57

LONDON BRIEFING: Phoenix Group hails "impressive" first-half

(Alliance News) - Stocks in London are called lower on Monday, as investors focus on the week's upcoming central bank decisions.

Read more
18 Sep 2023 07:18

US FDA approves GSK treatment for myelofibrosis

(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.

Read more
15 Sep 2023 21:52

GSK's Ojjaara approved in US for myelofibrosis patients with anaemia

(Alliance News) - GSK PLC on Friday said Ojjaara, also known as momelotinib, has been approved in the US and the "first and only" treatment indicated for myelofibrosis patients with anaemia.

Read more
11 Sep 2023 08:24

Japan accepts GSK's regulatory filing for momelotinib for blood cancer

(Alliance News) - GSK PLC on Monday reported regulatory progress for momelotinib, as Japan's Ministry of Health, Labour & Welfare accepted a review for the blood cancer-focused drug.

Read more
11 Sep 2023 07:54

LONDON BRIEFING: Restaurant Group sells Frankie & Benny's and Chiquito

(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.

Read more
6 Sep 2023 09:32

LONDON BROKER RATINGS: Shore says 'buy' B&M; Peel Hunt likes Halfords

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
4 Sep 2023 06:00

More UK babies to need hospital treatment over delay of GSK's RSV jab

(Alliance News) - The nation's top children's doctor has warned a delay on a new vaccine to combat respiratory syncytial virus, or RSV, will mean more babies and infants will need hospital treatment this winter.

Read more
1 Sep 2023 09:11

GSK antibody accepted for Japan review, Goldman Sachs reduces stake

(Alliance News) - GSK PLC on Friday said a new drug application for its monoclonal antibody mepolizumab has been accepted for review by the Japanese government.

Read more
1 Sep 2023 07:49

LONDON BRIEFING: Stocks seen higher; UK house prices continue to fall

(Alliance News) - Stocks in London are set to open higher on Friday as markets looked ahead to a data-heavy day.

Read more
1 Sep 2023 07:12

Japan considering GSK's Nucala drug for sinusitis treatment

(Sharecast News) - Japanese regulators are reviewing a new drug application for GSK's Nucala treatment to be used for the treatment of form of adult sinusitis, the biopharma giant announced on Friday.

Read more
23 Aug 2023 12:10

LONDON MARKET MIDDAY: Stocks rise but pound slumps on sub-par UK data

(Alliance News) - Stocks in Europe were on the up heading into Wednesday afternoon, with equity markets in a confident mood on the eve of the Jackson Hole central banking event, shaking off tepid economic data which hurt the pound and euro.

Read more
23 Aug 2023 08:17

GSK gets positive results from shingles trial of Shingrix in China

(Alliance News) - GSK PLC on Wednesday celebrated positive results from the first-ever efficacy trial of its preventative shingles treatment, Shingrix, in China.

Read more
23 Aug 2023 07:04

GSK reports positive results from shingles vaccine trials in China

(Sharecast News) - GSK reported significant positive findings from its first efficacy trial of the 'Shingrix' shingles vaccine in China on Wednesday.

Read more
22 Aug 2023 13:09

UK's Wood Group raises profit forecast on contract wins; shares rise

CFO David Kemp to retire

*

Read more
91011121314151617

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.